Carl E. Frasch
8Patents
7h-index
5Co-inventors
56Inventor score
Filing activity: May 1, 1985 → Nov 2, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4601903A | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease | Human Necessities | 196 | Expired |
| US8048432B2 | Polysaccharide-protein conjugate vaccines | Emerging Cross-Sectional Technologies | 14 | Active |
| US8465749B2 | Polysaccharide-protein conjugate vaccines | Emerging Cross-Sectional Technologies | 12 | Active |
| US9173931B2 | Process for preparing polysaccharide-protein conjugate vaccines | Emerging Cross-Sectional Technologies | 10 | Active |
| US8753649B2 | Polysaccharide-protein conjugate vaccines | Emerging Cross-Sectional Technologies | 9 | Active |
| US9474795B2 | Polysaccharide-protein conjugate vaccines | Emerging Cross-Sectional Technologies | 9 | Active |
| US9198976B2 | Polysaccharide-protein conjugate vaccines | Emerging Cross-Sectional Technologies | 8 | Active |
| US9562894B2 | Method of detecting the presence of an antibody in a sample | Physics | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.